AngioDynamics, Inc. designs, manufactures, and sells various medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and vascular access; and for use in oncology and surgical settings in the United States and internationally. The company provides NanoKnife ablation systems for the surgical ablation of soft tissues; solero microwave tissue ablation systems; and radiofrequency ablation products for ablating solid cancerous or benign tumors. It also offers BioSentry tract …
Over the last 12 months, insiders at AngioDynamics, Inc. have bought $202,847 and sold $0 worth of AngioDynamics, Inc. stock.
On average, over the past 5 years, insiders at AngioDynamics, Inc. have bought $516,566 and sold $770,544 worth of stock each year.
Highest buying activity among insiders over the last 12 months: Clemmer James C (President and CEO) — $187,600. Nighan Warren JR (SVP Quality and Regulatory) — $10,570. Trowbridge Stephen A (EVP and CFO) — $9,962.
The last purchase of 100 shares for transaction amount of $608 was made by Nighan Warren JR (SVP Quality and Regulatory) on 2024‑10‑10.
2024-10-10 | SVP Quality and Regulatory | 100 0.0002% | $6.08 | $608 | +13.93% | |||
2024-10-08 | EVP and CFO | 1,700 0.0033% | $5.86 | $9,962 | +18.88% | |||
2024-10-07 | President and CEO | 20,000 0.0399% | $6.03 | $120,600 | +14.59% | |||
2024-10-07 | SVP Quality and Regulatory | 768 0.0015% | $6.09 | $4,677 | +14.59% | |||
2024-04-08 | President and CEO | 10,000 0.0254% | $6.70 | $67,000 | +3.47% | |||
2023-01-31 | Sale | SVP Global Operations and R&D | 4,633 0.0117% | $12.95 | $59,997 | -34.41% | ||
2022-10-12 | EVP and CFO | 1,083 0.0027% | $13.82 | $14,967 | -23.49% | |||
2022-10-10 | President and CEO | 10,000 0.0264% | $15.00 | $150,000 | -24.76% | |||
2022-07-29 | Sale | SVP Global Operations and R&D | 5,000 0.0126% | $22.44 | $112,200 | -43.32% | ||
2022-04-28 | Sale | SVP Global Operations and R&D | 3,513 0.009% | $22.44 | $78,832 | -37.25% | ||
2022-04-12 | Sale | director | 1,299 0.0034% | $23.26 | $30,215 | -34.97% | ||
2022-04-11 | Sale | 7,500 0.0197% | $23.05 | $172,838 | -31.92% | |||
2022-01-12 | EVP and CFO | 2,000 0.0052% | $22.64 | $45,280 | -6.16% | |||
2022-01-11 | President and CEO | 20,000 0.0498% | $22.84 | $456,800 | -11.60% | |||
2021-10-20 | Sale | SVP Global Operations and R&D | 6,988 0.0176% | $27.97 | $195,454 | -21.70% | ||
2021-10-15 | Sale | Sr. VP/GM, Global VIT | 24,000 0.0627% | $27.92 | $670,080 | -18.23% | ||
2021-10-05 | Sale | SVP/GM, Vascular Access | 21,496 0.0543% | $27.15 | $583,616 | -17.96% | ||
2021-04-14 | Sale | SVP Global Operations and R&D | 7,000 0.0182% | $23.93 | $167,510 | +6.62% | ||
2021-01-20 | Sale | director | 13,000 0.0335% | $18.53 | $240,890 | +35.77% | ||
2020-08-11 | EVP and CFO | 2,026 0.0055% | $9.38 | $19,004 | +123.55% |
Clemmer James C | President and CEO | 681582 1.6774% | $8.69 | 8 | 0 | +14.85% |
Trowbridge Stephen A | EVP and CFO | 172711 0.425% | $8.69 | 4 | 2 | +31.3% |
Nighan Warren JR | SVP Quality and Regulatory | 45877 0.1129% | $8.69 | 2 | 0 | |
HOBBS EAMONN P | President & CEO | 100401 0.2471% | $8.69 | 3 | 27 | +11.48% |
BUCCI VINCENT | director | 86696 0.2134% | $8.69 | 9 | 0 | <0.0001% |
BlackRock | $27.49M | 11.69 | 4.68M | -7.17% | -$2.12M | <0.01 | |
The Vanguard Group | $13.11M | 5.58 | 2.23M | -1.57% | -$209,007.24 | <0.0001 | |
Systematic Financial Management LLC | $11.43M | 4.86 | 1.95M | +0.75% | +$84,733.46 | 0.32 | |
Morgan Stanley | $11.02M | 4.68 | 1.88M | -0.51% | -$56,070.26 | <0.01 | |
Dimensional Fund Advisors | $7.96M | 3.38 | 1.36M | -8.98% | -$784,936.44 | <0.01 |